KALA BIO, INC. Investment Income, Interest
KALA BIO, INC. (KALA) reported Investment Income, Interest of $140.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-19
- KALA BIO, INC. investment income, interest for the quarter ending 2026-06-30 was $140.00K, a 65.60% decline year-over-year.
- KALA BIO, INC. investment income, interest for the quarter ending 2026-03-31 was $74.00K, a 84.02% decline year-over-year.
- KALA BIO, INC. investment income, interest for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- KALA BIO, INC. investment income, interest for the quarter ending 2025-09-30 was $270.00K, a 52.63% decline year-over-year.
- KALA BIO, INC. investment income, interest for fiscal 2025 was $1.14M, a 44.55% decline from fiscal 2024.
- KALA BIO, INC. investment income, interest for fiscal 2024 was $2.06M, a 24.16% decline from fiscal 2023.
- KALA BIO, INC. investment income, interest for fiscal 2023 was $2.71M, a 308.28% increase from fiscal 2022.
- KALA BIO, INC. investment income, interest for fiscal 2022 was $664.00K, a 538.46% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $140.00K 10-Q · filed 2026-08-19 | $214.00K 10-Q · filed 2026-08-19 | $214.00K derived: sum of 3 quarters · filed 2026-08-19 | $484.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $74.00K 10-Q · filed 2026-05-15 | $74.00K derived: sum of 2 quarters · filed 2026-05-15 | $344.00K derived: sum of 3 quarters · filed 2026-05-15 | $751.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $270.00K derived: sum of 2 quarters · filed 2026-04-15 | $677.00K derived: sum of 3 quarters · filed 2026-08-19 | $1.14M 10-K · filed 2026-04-15 |
| 2025-09-30 | $270.00K 10-Q · filed 2025-11-19 | $677.00K derived: sum of 2 quarters · filed 2026-08-19 | $1.14M 10-Q · filed 2025-11-19 | $1.62M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $407.00K 10-Q · filed 2026-08-19 | $870.00K 10-Q · filed 2026-08-19 | $1.35M derived: sum of 3 quarters · filed 2026-08-19 | $1.92M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $463.00K 10-Q · filed 2026-05-15 | $941.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.51M derived: sum of 3 quarters · filed 2026-05-15 | $2.02M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $478.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.05M derived: sum of 2 quarters · filed 2026-04-15 | $1.55M derived: sum of 3 quarters · filed 2026-04-15 | $2.06M 10-K · filed 2026-04-15 |
| 2024-09-30 | $570.00K 10-Q · filed 2025-11-19 | $1.07M derived: sum of 2 quarters · filed 2025-11-19 | $1.58M 10-Q · filed 2025-11-19 | $2.19M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $504.00K 10-Q · filed 2025-08-08 | $1.01M 10-Q · filed 2025-08-08 | $1.62M derived: sum of 3 quarters · filed 2025-08-08 | $2.33M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $504.00K 10-Q · filed 2025-05-14 | $1.11M derived: sum of 2 quarters · filed 2025-05-14 | $1.82M derived: sum of 3 quarters · filed 2025-05-14 | $2.54M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $610.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.32M derived: sum of 2 quarters · filed 2025-03-31 | $2.04M derived: sum of 3 quarters · filed 2025-03-31 | $2.71M 10-K · filed 2025-03-31 |
| 2023-09-30 | $708.00K 10-Q · filed 2024-11-12 | $1.43M derived: sum of 2 quarters · filed 2024-11-12 | $2.10M 10-Q · filed 2024-11-12 | $2.46M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $718.00K 10-Q · filed 2024-08-06 | $1.39M 10-Q · filed 2024-08-06 | $1.75M derived: sum of 3 quarters · filed 2024-08-06 | $1.98M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $675.00K 10-Q · filed 2024-05-14 | $1.03M derived: sum of 2 quarters · filed 2024-05-14 | $1.26M derived: sum of 3 quarters · filed 2024-05-14 | $1.33M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $354.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $588.00K derived: sum of 2 quarters · filed 2024-03-29 | $656.00K derived: sum of 3 quarters · filed 2024-03-29 | $664.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $234.00K 10-Q · filed 2023-11-13 | $302.00K derived: sum of 2 quarters · filed 2023-11-13 | $310.00K 10-Q · filed 2023-11-13 | $322.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $68.00K 10-Q · filed 2023-08-04 | $76.00K 10-Q · filed 2023-08-04 | $88.00K derived: sum of 3 quarters · filed 2023-08-04 | $104.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $8.00K 10-Q · filed 2023-05-09 | $20.00K derived: sum of 2 quarters · filed 2023-05-09 | $36.00K derived: sum of 3 quarters · filed 2023-05-09 | $69.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $28.00K derived: sum of 2 quarters · filed 2023-03-03 | $61.00K derived: sum of 3 quarters · filed 2023-03-03 | $104.00K 10-K · filed 2023-03-03 |
| 2021-09-30 | $16.00K 10-Q · filed 2022-11-08 | $49.00K derived: sum of 2 quarters · filed 2022-11-08 | $92.00K 10-Q · filed 2022-11-08 | $134.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $33.00K 10-Q · filed 2022-08-11 | $76.00K 10-Q · filed 2022-08-11 | $118.00K derived: sum of 3 quarters · filed 2022-08-11 | $169.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $43.00K 10-Q · filed 2022-05-16 | $85.00K derived: sum of 2 quarters · filed 2022-05-16 | $136.00K derived: sum of 3 quarters · filed 2022-05-16 | $238.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $93.00K derived: sum of 2 quarters · filed 2022-03-29 | $195.00K derived: sum of 3 quarters · filed 2022-03-29 | $493.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $51.00K 10-Q · filed 2021-11-15 | $153.00K derived: sum of 2 quarters · filed 2021-11-15 | $451.00K 10-Q · filed 2021-11-15 | $835.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $102.00K 10-Q · filed 2021-08-05 | $400.00K 10-Q · filed 2021-08-05 | $784.00K derived: sum of 3 quarters · filed 2021-08-05 | $1.35M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $298.00K 10-Q · filed 2021-05-05 | $682.00K derived: sum of 2 quarters · filed 2021-05-05 | $1.25M derived: sum of 3 quarters · filed 2021-05-05 | $1.90M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $384.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $955.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.60M derived: sum of 3 quarters · filed 2021-02-25 | $2.36M 10-K · filed 2021-02-25 |
| 2019-09-30 | $571.00K 10-Q · filed 2020-11-05 | $1.22M derived: sum of 2 quarters · filed 2020-11-05 | $1.97M 10-Q · filed 2020-11-05 | $2.81M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $646.00K 10-Q · filed 2020-08-06 | $1.40M 10-Q · filed 2020-08-06 | $2.24M derived: sum of 3 quarters · filed 2020-08-06 | $2.57M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $756.00K 10-Q · filed 2020-05-07 | $1.59M derived: sum of 2 quarters · filed 2020-05-07 | $1.92M derived: sum of 3 quarters · filed 2020-05-07 | $2.23M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $839.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $1.16M derived: sum of 2 quarters · filed 2020-02-12 | $1.48M derived: sum of 3 quarters · filed 2020-02-12 | $1.69M 10-K · filed 2020-02-12 |
| 2018-09-30 | $325.00K 10-Q · filed 2019-11-07 | $638.00K derived: sum of 2 quarters · filed 2019-11-07 | $848.00K 10-Q · filed 2019-11-07 | $1.10M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $313.00K 10-Q · filed 2019-08-06 | $522.00K 10-Q · filed 2019-08-06 | $773.00K derived: sum of 3 quarters · filed 2019-08-06 | $967.00K derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $209.00K 10-Q · filed 2019-05-09 | $460.00K derived: sum of 2 quarters · filed 2019-05-09 | $654.00K derived: sum of 3 quarters · filed 2019-05-09 | $691.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $445.00K derived: sum of 2 quarters · filed 2019-03-12 | $482.00K derived: sum of 3 quarters · filed 2019-03-12 | $527.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $194.00K 10-Q · filed 2018-11-08 | $231.00K derived: sum of 2 quarters · filed 2018-11-08 | $276.00K 10-Q · filed 2018-11-08 | $334.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $37.00K 10-Q · filed 2018-08-09 | $83.00K 10-Q · filed 2018-08-09 | $140.00K derived: sum of 3 quarters · filed 2018-08-09 | $200.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $46.00K 10-Q · filed 2018-05-10 | $103.00K derived: sum of 2 quarters · filed 2018-05-10 | $163.00K derived: sum of 3 quarters · filed 2018-05-10 | $193.00K derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $117.00K derived: sum of 2 quarters · filed 2018-04-02 | $147.00K derived: sum of 3 quarters · filed 2018-04-02 | $147.00K 10-K · filed 2018-04-02 |
| 2016-09-30 | $60.00K 10-Q · filed 2017-11-07 | $90.00K derived: sum of 2 quarters · filed 2017-11-07 | $90.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $30.00K 10-Q · filed 2017-08-31 | $30.00K 10-Q · filed 2017-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |